Hing L Sham

This inventor holds 92 USPTO granted patents, plus 4 CIPO patents and 4 EPO patents, primarily in Pharmaceutical Inhibitors (CPC class 548204). Top assignees: Abbott Laboratories Corporation, Global Blood Therapeutics, Inc., Abbvie Inc.. Active years: 1988-2023.

USPTO Granted Patents = 92

% Patents Active = 77.2

CIPO Patents = 4 (Patent Applications = 13)

EPO Patents = 4 (Patent Applications = 3)

Average Co-Inventor Count = 5.8

ph-index = 17

Forward Citations = 1,018(Granted Patents)

Forward Citations (Not Self Cited) = 944(Dec 10, 2025)

Inventors with similar research interests:

Location History:

Waukegan, IL (US) (1988)
Gurnee, IL (US) (1989 - 2003)
Mundelein, IL (US) (1995 - 2011)
Vernon Hills, IL (US) (2001 - 2014)
South San Francisco, CA (US) (2008 - 2021)
Palo Alto, CA (US) (2013 - 2023)

Company Filing History:

79 out of 4,186

Abbott Laboratories Corporation

patents

5 out of 59

Global Blood Therapeutics, Inc.

Imago Pharmaceuticals, Inc.

Elan Pharmaceuticals, Inc.

patents

Years Active: 1988-2023

Loading Chart...

Areas of Expertise:

Histone Methyltransferase

Hemoglobin Modulators

Kallikrein Inhibitors

Jun N-Terminal Kinase

Dipeptidyl Peptidase-IV

Acetyl-CoA Carboxylase

Retroviral Protease

Farnesyltransferase

Cell Proliferation

Neuraminidases

Protein Kinase

AMPK Activators

92 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11584734 - Tricyclic compounds as histone methyltransferase inhibitors (2023-02-21),

2. 11014884 - Modulators of hemoglobin (2021-05-25),

3. 10144746 - Bridged bicyclic kallikrein inhibitors (2018-12-04),

4. 9815853 - Bridged bicyclic kallikrein inhibitors (2017-11-14),

5. 9796706 - Inhibitors of Jun N-terminal kinase (2017-10-24),

6. 9695166 - Pyrazolopyridine pyrazolopyrimidine and related compounds (2017-07-04),

7. 9493485 - Spirocyclic dihydro-thiazine and dihydro-oxazine BACE inhibitors, and compositions and uses thereof (2016-11-15),

8. 9073891 - Inhibitors of Jun N-terminal kinase (2015-07-07),

9. 8748627 - Acetyl-CoA carboxylase (ACC) inhibitors and their use in diabetes, obesity and metabolic syndrome (2014-06-10),

10. 8735595 - Acetyl-CoA carboxylase (ACC) inhibitors and their use in diabetes, obesity and metabolic syndrome (2014-05-27),

11. 8637546 - Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-IV (DDP-IV) (2014-01-28),

12. 8450363 - Inhibitors of Jun N-terminal kinase (2013-05-28),

13. 8207350 - Acetyl-CoA carboxylase (ACC) inhibitors and their use in diabetes, obesity and metabolic syndrome (2012-06-26),

14. 8119664 - Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-IV (DPP-IV) (2012-02-21),

15. 7968707 - Retroviral protease inhibiting compounds (2011-06-28),

Title: Inventor Hing L Sham - Pioneering Innovations in Gurnee

Introduction: Hing L Sham is a distinguished inventor based in Gurnee, Illinois, known for his groundbreaking contributions to various fields through his innovative creations.

Latest Patents: Hing L Sham holds several patents in the areas of technology and engineering, showcasing his continuous dedication to pushing the boundaries of what is possible.

Career Highlights: Throughout his illustrious career, Hing L Sham has demonstrated a remarkable ability to transform ideas into tangible inventions that have the potential to revolutionize industries.

Collaborations: Hing L Sham has collaborated with leading experts in the field, fostering a culture of innovation and knowledge-sharing that has led to the development of cutting-edge solutions.

Conclusion: Inventor Hing L Sham's relentless pursuit of innovation and his passion for creating impactful inventions make him a true trailblazer in the world of technology.